|
|
Volumn 313, Issue 5784, 2006, Pages 154-
|
|
Cancer research. Fake data, but could the idea still be right?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ERLOTINIB;
QUINAZOLINE DERIVATIVE;
ANEUPLOIDY;
ARTICLE;
CONTROLLED CLINICAL TRIAL;
GENETIC MARKER;
GENETICS;
HETEROZYGOSITY LOSS;
HUMAN;
MOUTH DISEASE;
MOUTH TUMOR;
PATHOLOGY;
RISK FACTOR;
SCIENTIFIC MISCONDUCT;
ANEUPLOIDY;
ANTINEOPLASTIC AGENTS;
CONTROLLED CLINICAL TRIALS;
GENETIC MARKERS;
HUMANS;
LOSS OF HETEROZYGOSITY;
MOUTH DISEASES;
MOUTH NEOPLASMS;
QUINAZOLINES;
RISK FACTORS;
SCIENTIFIC MISCONDUCT;
|
|
EID: 33746442078
PISSN: None
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.313.5784.154 Document Type: Article |
|
Times cited : (11)
|
|
References (0)
|
